Sector Gamma AS Sells 22,901 Shares of Humana Inc (NYSE:HUM)

Sector Gamma AS decreased its stake in Humana Inc (NYSE:HUM) by 34.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 43,999 shares of the insurance provider’s stock after selling 22,901 shares during the period. Humana accounts for about 1.9% of Sector Gamma AS’s holdings, making the stock its 20th biggest position. Sector Gamma AS’s holdings in Humana were worth $11,249,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in HUM. Maverick Capital Ltd. increased its stake in shares of Humana by 150.9% in the second quarter. Maverick Capital Ltd. now owns 1,550,726 shares of the insurance provider’s stock worth $411,408,000 after purchasing an additional 932,778 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of Humana by 1.8% in the second quarter. Wells Fargo & Company MN now owns 1,367,476 shares of the insurance provider’s stock worth $362,790,000 after purchasing an additional 24,314 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Humana by 1.8% in the second quarter. Bank of New York Mellon Corp now owns 1,181,373 shares of the insurance provider’s stock worth $313,417,000 after purchasing an additional 21,207 shares in the last quarter. Amundi Pioneer Asset Management Inc. increased its stake in shares of Humana by 76.7% in the second quarter. Amundi Pioneer Asset Management Inc. now owns 877,582 shares of the insurance provider’s stock worth $232,822,000 after purchasing an additional 380,979 shares in the last quarter. Finally, California Public Employees Retirement System increased its stake in shares of Humana by 8.6% in the third quarter. California Public Employees Retirement System now owns 850,334 shares of the insurance provider’s stock worth $217,405,000 after purchasing an additional 67,252 shares in the last quarter. 92.93% of the stock is currently owned by institutional investors and hedge funds.

Several equities analysts have recently weighed in on HUM shares. Cantor Fitzgerald upgraded shares of Humana from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $300.00 to $345.00 in a research note on Monday, August 12th. Berenberg Bank reiterated a “buy” rating on shares of Humana in a research note on Monday, October 21st. Citigroup boosted their price objective on shares of Humana from $340.00 to $350.00 and gave the company a “buy” rating in a research note on Thursday. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday. Finally, Mizuho began coverage on shares of Humana in a research note on Thursday, October 17th. They set a “buy” rating and a $316.00 price objective for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $322.63.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Humana stock traded up $2.44 during mid-day trading on Friday, hitting $317.58. 1,173,375 shares of the company traded hands, compared to its average volume of 1,220,728. Humana Inc has a one year low of $225.65 and a one year high of $342.03. The stock has a market cap of $39.82 billion, a price-to-earnings ratio of 21.83, a price-to-earnings-growth ratio of 1.27 and a beta of 0.85. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.75 and a current ratio of 1.75. The stock has a fifty day moving average price of $277.48 and a 200-day moving average price of $270.93.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, November 6th. The insurance provider reported $5.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.58 by $0.45. Humana had a net margin of 4.13% and a return on equity of 22.47%. The business had revenue of $16.24 billion during the quarter, compared to analyst estimates of $16.15 billion. During the same period in the previous year, the business posted $4.58 earnings per share. Humana’s revenue for the quarter was up 14.3% on a year-over-year basis. Sell-side analysts predict that Humana Inc will post 17.75 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.55 per share. The ex-dividend date of this dividend is Monday, December 30th. This represents a $2.20 annualized dividend and a yield of 0.69%. Humana’s payout ratio is presently 15.12%.

In other Humana news, insider Brian P. Leclaire sold 7,239 shares of Humana stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $289.70, for a total transaction of $2,097,138.30. Following the completion of the sale, the insider now directly owns 12,994 shares in the company, valued at $3,764,361.80. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.54% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Story: Conference Calls and Individual Investors

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Leave a Reply

Your email address will not be published. Required fields are marked *

*